Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Ridker, Paul M, Danielson, Eleanor, Fonseca, Francisco A.H., Genest, Jacques, Gotto, Antonio M., Kastelein, John J.P., Koenig, Wolfgang, Libby, Peter +6 more·2008·New England Journal of Medicine
DOI 10.1056/nejmoa0807646

Cited by (1,053)

Items 601–700 of 1,053

  1. Cytokine Biomarkers, Endothelial Inflammation, and Atherosclerosis in the Metabolic Syndrome: Emerging Concepts
    Ali Abbas Rizvi · 2009 · The American Journal of the Medical Sciences
  2. Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score
    Stig Lyngbæk, Jacob Louis Marott, Thomas Berend Sehestedt, Tine W. Hansen, Michael Hecht Olsen, Ove Andersen, Allan R Linneberg, Steen B. Haugaard, Jesper Eugen‐Olsen, Peter Riis Hansen et al. · 2012 · International Journal of Cardiology
  3. Cholesterol and cardiovascular disease in the elderly. Facts and gaps.
    Francisco Javier Félix-Redondo, María Grau, Daniel J. Fernandez-Berges · 2013 · Europe PMC (PubMed Central)
  4. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiovascular Risk Factors
    Alan Thomas Remaley, Nader Rifai, G. Russell Warnick · 2012 · Elsevier eBooks
  5. Metabolic Complications and Glucose Metabolism in HIV Infection: A Review of the Evidence
    Amanda L. Willig, Edgar Turner Overton · 2016 · Current HIV/AIDS Reports
  6. Vascular inflammation and low‐density lipoproteins: is cholesterol the link? A lesson from the clinical trials
    Alberico Luigi Catapano, Angela Pirillo, Giuseppe Danilo Norata · 2017 · British Journal of Pharmacology
  7. Hypertension: Focus on autoimmunity and oxidative stress
    Heather Yvonne Small, Serena Migliarino, Marta Cześnikiewicz‐Guzik, Tomasz Jan Guzik · 2018 · Free Radical Biology and Medicine
  8. Diabetes Mellitus and Cardiovascular Disease: Exploring Epidemiology, Pathophysiology, and Treatment Strategies
    Nawfal Hasan Siam, Nayla Nuren Snigdha, Noushin Tabasumma, Irin Parvin · 2024 · Reviews in Cardiovascular Medicine
  9. Untitled work
    Robinson · 2012 · 10.1016/j.amjcard.2012.07.007
  10. Approaches based on artificial intelligence and the internet of intelligent things to prevent the spread of COVID-19: Scoping review
    Adly, Aya Sedky, Adly, Afnan Sedky, Adly, Mahmoud Sedky · 2020 · Journal of Medical Internet Research
  11. The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury
    Sabine Steffens, Fabrizio Montecucco, François Mach · 2009 · Thrombosis and Haemostasis
  12. Primary Prevention With Statin Therapy in the Elderly
    Paul M. Ridker, Eva Lonn, Nina P. Paynter, Robert J. Glynn, Salim Yusuf · 2017 · Circulation
  13. Statin use and risk of developing diabetes: results from the Diabetes Prevention Program
    Crandall, Jill P, Mather, Kieren, Rajpathak, Swapnil N, Goldberg, Ronald B, Watson, Karol, Foo, Sandra, Ratner, Robert, Barrett-Connor, Elizabeth, Temprosa, Marinella · 2017 · BMJ Open Diabetes Research & Care
  14. Targeting the NF-κB Pathway in Cancer Therapy
    Derek J. Erstad, James C. Cusack · 2013 · Surgical Oncology Clinics of North America
  15. Inflammatory Concepts of Obesity
    Viviane Zorzanelli Rocha, Eduardo J.E. Folco · 2011 · International Journal of Inflammation
  16. Molecular and cellular mechanisms of the thrombotic complications of atherosclerosis
    Peter Libby · 2008 · Journal of Lipid Research
  17. Nitric Oxide: Considerations for the Treatment of Ischemic Stroke
    Nicole A. Terpolilli, Michael A. Moskowitz, Nikolaus Plesnila · 2012 · Journal of Cerebral Blood Flow & Metabolism
  18. Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance
    Nicholls, StephenJ, Lincoff, A Michael, Bays, Harold E, Cho, Leslie, Grobbee, Diederick E, Kastelein, John JP, Libby, Peter, Moriarty, Patrick M, Plutzky, Jorge, Ray, Kausik K et al. · 2021 · American Heart Journal
  19. Effect of Statins on Serum level of hs-CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Kandelouei, Tahmineh, Abbasifard, Mitra, Imani, Danyal, Aslani, Saeed, Razi, Bahman, Fasihi, Mahdieh, Shafiekhani, Sajad, Mohammadi, Keyhan, Jamialahmadi, Tannaz, Reiner, Željko et al. · 2022 · Mediators of Inflammation
  20. A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy (‘polypill’) on cardiovascular risk factors
    Fatemeh Malekzadeh, Tom P Marshall, Akram Pourshams, M. Gharravi, A. Aslani, Alireza Nateghi, Mansoor Rastegarpanah, Masoud Khoshnia, Shahryar Semnani, Rasool Salahi et al. · 2010 · International Journal of Clinical Practice
  21. Non-adherence to statin therapy: a major challenge for preventive cardiology
    TR Bates, VM Connaughton, Gerald Francis Watts · 2009 · Expert Opinion on Pharmacotherapy
  22. Electrochemical Immunosensor for Simultaneous Detection of Dual Cardiac Markers Based on a Poly(Dimethylsiloxane)-Gold Nanoparticles Composite Microfluidic Chip: A Proof of Principle
    Fang Zhou, Min Lu, Wei Wang, Zhiping Bian, Jianrong Zhang, Jun‐Jie Zhu · 2010 · Clinical Chemistry
  23. Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases
    Alessia Faccini, Juan Carlos Kaski, Paolo Guido Camici · 2016 · European Heart Journal
  24. Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2014 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline
    John R. Downs, Patrick G. O’Malley · 2015 · Annals of Internal Medicine
  25. Foundations of Lifestyle Medicine and its Evolution
    David Lippman, Mariah Stump, Erica Veazey, Sley Tanigawa Guimarães, Richard M. Rosenfeld, John H. Kelly, Dean M. Ornish, David L. Katz · 2024 · Mayo Clinic Proceedings Innovations Quality & Outcomes
  26. A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice
    Jahagirdar, Ravi, Zhang, Haiyan, Azhar, Salman, Tobin, Jennifer, Attwell, Sarah, Yu, Raymond, Wu, Jin, McLure, Kevin G., Hansen, Henrik C., Wagner, Gregory S. et al. · 2014 · Atherosclerosis
  27. Small Dense Low-Density Lipoproteins Cholesterol can Predict Incident Cardiovascular Disease in an Urban Japanese Cohort: The Suita Study
    Hidenori Arai, Yoshihiro Kokubo, Makoto Watanabe, Tatsuya Sawamura, Yasuki Ito, Asako Minagawa, Tomonori Okamura, Yoshihiro Miyamato · 2012 · Journal of Atherosclerosis and Thrombosis
  28. Evaluation of Time to Benefit of Statins for the Primary Prevention of Cardiovascular Events in Adults Aged 50 to 75 Years: A Meta-analysis
    Yourman, Lindsey C., Cenzer, Irena S., Boscardin, W. John, Nguyen, Brian T., Smith, Alexander K., Schonberg, Mara A., Schoenborn, Nancy L., Widera, Eric W., Orkaby, Ariela, Rodriguez, Annette et al. · 2021 · JAMA Internal Medicine
  29. The Influence of Anti-Infective Periodontal Treatment on C-Reactive Protein: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Ryan T. Demmer, Ludovic Trinquart, Aleksandra M. Zuk, Benjamin C. Fu, Josefin Blomkvist, Bryan S. Michalowicz, Philippe Ravaud, Moı̈se Desvarieux · 2013 · PLoS ONE
  30. Is There Potential for Repurposing Statins as Novel Antimicrobials?
    Emma Hennessy, Claire Adams, F. Jerry Reen, Fergal O’Gara · 2016 · Antimicrobial Agents and Chemotherapy
  31. Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates
    Marnix Lameijer, Tina Binderup, Mandy M. T. van Leent, Max L. Senders, François Fay, Joost Malkus, Brenda L. Sánchez-Gaytán, Abraham J. P. Teunissen, Nicolas A. Karakatsanis, Philip M. Robson et al. · 2018 · Nature Biomedical Engineering
  32. Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues
    Samuel C. R. Sherratt, Peter Libby, Matthew Jay Budoff, Deepak L. Bhatt, Richard Preston Mason · 2022 · Current Atherosclerosis Reports
  33. Nonoptimal lipids commonly present in young adults and coronary calcium later in life: the CARDIA (Coronary Artery Risk Development in Young Adults) study
    Pletcher, Mark J., Bibbins-Domingo, Kirsten, Liu, Kiang, Sidney, Steve, Lin, Feng, Vittinghoff, Eric, Hulley, Stephen B. · 2010 · Annals of Internal Medicine
  34. Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy
    Ridker, Paul M, Rifai, Nader, MacFadyen, Jean, Glynn, Robert J., Jiao, Lixia, Steg, Ph. Gabriel, Miller, Michael, Brinton, Eliot A., Jacobson, Terry A., Tardif, Jean-Claude et al. · 2022 · Circulation
  35. CRP and the risk of atherosclerotic events
    Paolo Calabrò, Enrica Golia, Edward T.H. Yeh · 2009 · Seminars in Immunopathology
  36. Effect of Statins on Cholesterol Crystallization and Atherosclerotic Plaque Stabilization
    George S. Abela, Ameeth Vedre, Abed Janoudi, Ruiping Huang, Sridevi Durga, Umesh U. Tamhane · 2011 · The American Journal of Cardiology
  37. Enrichment of Clinical Study Populations
    Robert Temple · 2010 · Clinical Pharmacology & Therapeutics
  38. Optimizing Statin Treatment for Primary Prevention of Coronary Artery Disease
    Rodney A. Hayward, Harlan M. Krumholz, Donna M. Zulman, Justin W. Timbie, Sandeep S. Vijan · 2010 · Annals of Internal Medicine
  39. High-Sensitivity Cardiac Troponin I and B-Type Natriuretic Peptide as Predictors of Vascular Events in Primary Prevention
    Brendan M. Everett, Tanja Zeller, Robert J. Glynn, Paul M. Ridker, Stefan Blankenberg · 2015 · Circulation
  40. Proof That Lower Is Better — LDL Cholesterol and IMPROVE-IT
    John Adams Jarcho, John F. Keaney · 2015 · New England Journal of Medicine
  41. Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials
    Stein, E. A., Giugliano, R. P., Koren, M. J., Raal, F. J., Roth, E. M., Weiss, R., Sullivan, D., Wasserman, S. M., Somaratne, R., Kim, J. B. et al. · 2014 · European Heart Journal
  42. Differential metabolic effects of distinct statins
    Koh, Kwang Kon, Sakuma, Ichiro, Quon, Michael J. · 2011 · Atherosclerosis
  43. Cholesterol Lowering, Cardiovascular Diseases, and the Rosuvastatin-JUPITER Controversy
    Michel de Lorgeril · 2010 · Archives of Internal Medicine
  44. Prognostic Value of Endothelial Microparticles in Patients with Heart Failure
    Toshimitsu Nozaki, Seigo Sugiyama, Koichi Sugamura, Keisuke Ohba, Yasushi Matsuzawa, Masaaki Konishi, Junichi Matsubara, Eiichi Akiyama, Hitoshi Sumida, Kunihiko Matsui et al. · 2010 · European Journal of Heart Failure
  45. Statins, Risk of Diabetes, and Implications on Outcomes in the General Population
    Kang-Ling Wang, Chia‐Jen Liu, Tze‐Fan Chao, Chi-Ming Huang, Cheng‐Hsueh Wu, Su‐Jung Chen, Tzeng‐Ji Chen, Shing‐Jong Lin, Chern‐En Chiang · 2012 · Journal of the American College of Cardiology
  46. Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year
    Jonathan Kay, Olga Morgacheva, Susan P. Messing, Joel M. Kremer, Jeffrey D. Greenberg, George W Reed, Ellen M. Gravallese, Daniel E. Furst · 2014 · Arthritis Research & Therapy
  47. Randomized Head-to-Head Comparison of Pitavastatin, Atorvastatin, and Rosuvastatin for Safety and Efficacy (Quantity and Quality of LDL) - The PATROL Trial -
    Keijiro Saku, Bo Zhang, Keita Noda, The PATROL Trial Investigators · 2011 · Circulation Journal
  48. Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection
    Álvaro Humberto Borges, Jemma L. O’Connor, Andrew N. Phillips, James D. Neaton, Birgit Grund, Jacqueline Neuhaus, Michael J. Vjecha, Alexandra Calmy, Kersten K. Koelsch, Jens Dilling Lundgren · 2016 · The Journal of Infectious Diseases
  49. PCSK9 inhibition and inflammation: A narrative review
    Massimiliano Ruscica, Lale S Tokgözoğlu, Alberto Corsini, Cesare Riccardo Sirtori · 2019 · Atherosclerosis
  50. The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better
    Omar Mhaimeed, Zain Ali Burney, Stacey L. Schott, Payal Kohli, Francoise Adeline Marvel, Seth Shay Martin · 2024 · American Journal of Preventive Cardiology
  51. Total and Individual Coronary Artery Calcium Scores as Independent Predictors of Mortality in Hemodialysis Patients
    Ronney S. Shantouf, Matthew Jay Budoff, Naser Ahmadi, Arshia Ghaffari, Ferdinand R. Flores, Ambarish Gopal, Nazanin Noori, Jennie Jing, Csaba Pal Kovesdy, Kamyar Kalantar‐Zadeh · 2010 · American Journal of Nephrology
  52. Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies
    Yanqiong Liu, Weizhong Tang, Jian Wang, Li Xie, Taijie Li, Yu He, Yan Deng, Qiliu Peng, Shan Li, Xue Ying Qin · 2013 · Cancer Causes & Control
  53. Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial
    Nina Chetty Raju, Qilong Yi, Mark Nidorf, Nick D. Fagel, Rajesh Hiralal, John W. Eikelboom · 2011 · Journal of Thrombosis and Thrombolysis
  54. Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist.
    C. Charles-Schoeman, M. González-Gay, I. Kaplan, M. Boy, J. Geier, Zhen Luo, Andrea L. Zuckerman, R. Riese · 2016 · Seminars in Arthritis & Rheumatism
  55. National lipid association annual summary of clinical lipidology 2016
    Bays, Harold E., Jones, Peter H., Orringer, Carl E., Brown, W. Virgil, Jacobson, Terry A. · 2016 · Journal of Clinical Lipidology
  56. Novel anti-inflammatory therapies for the treatment of atherosclerosis
    Razi Khan, Vincent Spagnoli, Jean‐Claude Tardif, Philippe L. L’Allier · 2015 · Atherosclerosis
  57. Obstructive Sleep Apnea, Inflammation, and the Metabolic Syndrome
    Andrew D. Calvin, Felipe N. Albuquerque, Francisco Alejandro López-Jiménez, Virend Kristen Somers · 2009 · Metabolic Syndrome and Related Disorders
  58. Impact of Metabolic Syndrome on Progression of Aortic Stenosis
    Capoulade, Romain, Clavel, Marie-Annick, Dumesnil, Jean G., Chan, Kwan L., Teo, Koon K., Tam, James W., Côté, Nancy, Mathieu, Patrick, Després, Jean-Pierre, Pibarot, Philippe · 2012 · Journal of the American College of Cardiology
  59. Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control
    Ray, Kausik K., Ginsberg, Henry N., Davidson, Michael H., Pordy, Robert, Bessac, Laurence, Minini, Pascal, Eckel, Robert H., Cannon, Christopher P. · 2016 · Circulation
  60. Long-term mipomersen treatment is associated with a reduction in cardiovascular events in patients with familial hypercholesterolemia
    Paul Barton Duell, Raul Dias Santos, Bridget‐Anne Kirwan, Joseph Lee Witztum, Sotirios Tsimikas, John J.P. Kastelein · 2016 · Journal of clinical lipidology
  61. Carotid Intima-Media Thickness as Surrogate for and Predictor of CVD
    Joseph F. Polak, Daniel H. O’Leary · 2016 · Global Heart
  62. Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society* Clinical Practice Guideline
    James L. Rosenzweig, George L. Bakris, Lars Berglund, Marie‐France Hivert, Edward S. Horton, Rita Rastogi Kalyani, Mohammad Hassan Murad, Bruno L Vergès · 2019 · The Journal of Clinical Endocrinology & Metabolism
  63. There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness
    Michael E. Makover, Michael David Shapiro, Peter Paul Toth · 2022 · American Journal of Preventive Cardiology
  64. The evolution of domain arrangements in proteins and interaction networks
    Erich Bornberg‐Bauer, Francois Beaussart, Sarah Kummerfeld, Sarah Amalia Teichmann, January Mikolaj Weiner · 2005 · Cellular and Molecular Life Sciences
  65. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial
    Mora, Samia, Caulfield, Michael P., Wohlgemuth, Jay, Chen, Zhihong, Superko, H. Robert, Rowland, Charles M., Glynn, Robert J., Ridker, Paul M, Krauss, Ronald M. · 2015 · Circulation
  66. Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysis
    Erqou, Sebhat, Lee, C. Christine, Adler, Amanda I. · 2014 · Diabetologia
  67. Effect of Statins on Fasting Plasma Glucose in Diabetic and Nondiabetic Patients
    Sukhija, Rishi, Prayaga, Sastry, Marashdeh, Mohammad, Bursac, Zoran, Kakar, Priyanka, Bansal, Darpan, Sachdeva, Rajesh, Kesan, Sree Hari, Mehta, Jawahar L. · 2009 · Journal of Investigative Medicine
  68. Identification and Management of Cardiometabolic Risk after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers
    Nash, Mark S., Groah, Suzanne L., Gater, David R., Dyson-Hudson, Trevor A., Lieberman, Jesse A., Myers, Jonathan, Sabharwal, Sunil, Taylor, Allen J., Consortium for Spinal Cord Medicine · 2018 · Topics in Spinal Cord Injury Rehabilitation
  69. Statin Use and Risk of Prostate Cancer Recurrence in Men Treated With Radiation Therapy
    C.A. Lawton · 2011 · Yearbook of Oncology
  70. Cytokines: Roles in Atherosclerosis Disease Progression and Potential Therapeutic Targets
    Joe W. E. Moss, Dipak P. Ramji · 2016 · Future Medicinal Chemistry
  71. Dyslipidemia, Diabetes and Atherosclerosis: Role of Inflammation and ROS-Redox-Sensitive Factors
    Elham Hasheminasabgorji, Jay C. Jha · 2021 · Biomedicines
  72. Exercise without Weight Loss Does Not Reduce C-Reactive Protein
    Timothy S. Church, Conrad P. Earnest, Angela M. Thompson, Elisa L. Priest, Ruben Q. Rodarte, Travis John Saunders, ROBERT ROSS, Steven N. Blair · 2010 · Medicine & Science in Sports & Exercise
  73. Inflammatory Mechanisms of Cardiovascular Remodeling
    Toshihisa Anzai · 2018 · Circulation Journal
  74. Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality
    Mara Sophie Vell, Rohit Seth Loomba, Arunkumar Krishnan, Kirk J. Wangensteen, Jonel Trebicka, Kate Townsend Creasy, Christian Trautwein, Eleonora Scorletti, Katharina Sophie Seeling, Leonida Hehl et al. · 2023 · JAMA Network Open
  75. C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive Statin Therapy
    Rishi Puri, Steven E. Nissen, Peter Libby, Mingyuan Shao, Christie Mitchell Ballantyne, P.J. Barter, M. John Chapman, Raimund M. Erbel, Joel S. Raichlen, Kiyoko Uno et al. · 2013 · Circulation
  76. Inflammation in Coronary Artery Disease
    Georgios Christodoulidis, Timothy J. Vittorio, Marat Fudim, Stamatios Lerakis, Constantine E. Kosmas · 2014 · Cardiology in Review
  77. Antiinflammatory Therapy in Clinical Care: The CANTOS Trial and Beyond
    Aaron W. Aday, Paul M. Ridker · 2018 · Frontiers in Cardiovascular Medicine
  78. Oxidative stress and endothelial dysfunction: Therapeutic implications
    Tommaso Gori, Thomas F. Münzel · 2011 · Annals of Medicine
  79. Statins and risk of treated incident diabetes in a primary care population
    Nur Lisa Zaharan, David James Williams, Kathleen Bennett · 2012 · British Journal of Clinical Pharmacology
  80. Effect of Statins on Skeletal Muscle
    Beth A. Parker, Paul D. Thompson · 2012 · Exercise and Sport Sciences Reviews
  81. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
    Writing Committee Members, Blumenthal, Roger S., Morris, Pamela B., Gaudino, Mario, Johnson, Heather M., Anderson, Timothy S., Bittner, Vera A., Blankstein, Ron, Brewer, LaPrincess C., Cho, Leslie et al. · 2026 · Circulation
  82. Markers of inflammation and CD8 T ‐cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV ‐infected individuals
    Chris Todd Longenecker, Nicholas Funderburg, Y Jiang, S. M. Debanne, Norma J. Storer, Danielle E. Labbato, M. M. Lederman, GA McComsey · 2013 · HIV Medicine
  83. Asymptomatic Carotid Artery Stenosis and the Risk of Ischemic Stroke According to Subtype in Patients With Clinical Manifest Arterial Disease
    Anne G. den Hartog, Sefanja Achterberg, Frans L. Moll, Laurens Jaap Kappelle, Frank L.J. Visseren, Yolanda van der Graaf, Ale Algra, Gert Jan de Borst · 2013 · Stroke
  84. High-Sensitivity C-Reactive Protein and Cardiovascular Disease Across Countries and Ethnicities
    Francisco Antônio Helfenstein Fonseca, Maria Cristina de Oliveira Izar · 2016 · Clinics
  85. Statins: Could an old friend help in the fight against COVID‐19?
    Raúl R. Rodrigues-Díez, Antonio Tejera‐Muñoz, Laura Márquez‐Expósito, Sandra Rayego‐Mateos, Laura Santos‐Sanchez, Vanessa A Marchant, Lucía Tejedor-Santamaria, Adrian Mario Ramos, Alberto Ortíz, Jesús Egido et al. · 2020 · British Journal of Pharmacology
  86. TMAO as a biomarker of cardiovascular events: a systematic review and meta-analysis
    Luigina Guasti, Silvia Galliazzo, Marta Molaro, Eleonora Visconti, Benedetta Pennella, Giovanni Vincenzo Gaudio, Alessandro Lupi, Anna Maria Grandi, Alessandro Squizzato · 2020 · Internal and Emergency Medicine
  87. Admission C – reactive protein after acute ischemic stroke is associated with stroke severity and mortality: The 'Bergen stroke study'
    Titto T. Idicula, Jan Christian Brøgger, Halvor Næss, Ulrike Waje‐Andreassen, Lars Thomassen · 2009 · BMC Neurology
  88. Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it
    Douglas Bruce Kell · 2013 · FEBS Journal
  89. Stabilization of atherosclerotic plaques: an update
    Seppo Ylä‐Herttuala, Jacob Fog Bentzon, Mat J.A.P. Daemen, Erling Falk, Héctor M. García‐García, J. Herrmann, Imo E. Hoefer, Suvi Jauhiainen, J. Wouter Jukema, Rob Krams et al. · 2013 · European Heart Journal
  90. Coronary Microvascular Dysfunction
    Shigeo Godo, Akira Suda, JUN C. TAKAHASHI, Satoshi Yasuda, Hiroaki Shimokawa · 2021 · Arteriosclerosis Thrombosis and Vascular Biology
  91. Myopathy in older people receiving statin therapy: a systematic review and meta‐analysis
    Roli B. Iwere, Jonathan Hewitt · 2015 · British Journal of Clinical Pharmacology
  92. Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality
    Christina M. Parrinello, Pamela L. Lutsey, Christie Mitchell Ballantyne, Aaron R. Folsom, James S. Pankow, Elizabeth Selvin · 2015 · American Heart Journal
  93. Effect of 24 Weeks of Statin Therapy on Systemic and Vascular Inflammation in HIV-Infected Subjects Receiving Antiretroviral Therapy
    Allison Ross Eckard, Y. Jiang, S. M. Debanne, Nicholas Funderburg, Grace A. McComsey · 2014 · The Journal of Infectious Diseases
  94. HIV positivity, protease inhibitor exposure and subclinical atherosclerosis: a systematic review and meta-analysis of observational studies
    Edward A Hulten, Joshua D. Mitchell, J Scally, B Gibbs, Todd C. Villines · 2009 · Heart
  95. Biomarkers and Cardiovascular Risk Assessment for Primary Prevention: An Update
    Lauren Gray Gilstrap, Thomas J. Wang · 2011 · Clinical Chemistry
  96. Elevated Hemostasis Markers after Pneumonia Increases One-Year Risk of All-Cause and Cardiovascular Deaths
    Sachin P. Yende, Gina D’Angelo, Florian Mayr, John A. Kellum, Lisa A. Weissfeld, Ata Murat Kaynar, Tammy Young, Kaikobad Irani, Derek C. Angus, for the GenIMS Investigators · 2011 · PLoS ONE
  97. Management of diabetic dyslipidemia: An update
    Ishwarlal Jialal, Gurdeep Singh · 2019 · World Journal of Diabetes
  98. High-sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death
    Pierpaolo Pellicori, Jufen Zhang, Joe J. Cuthbert, Alessia Urbinati, Parin Purvin Shah, Syed Kazmi, Andrew L. Clark, John G.F. Cleland · 2019 · Cardiovascular Research
  99. Sex specific cognitive differences in Parkinson disease
    Tyler H. Reekes, Christopher I. Higginson, Christina Raye Ledbetter, Niroshan Sathivadivel, Richard M. Zweig, Elizabeth A. Disbrow · 2020 · npj Parkinson s Disease
  100. An assessment by the Statin Diabetes Safety Task Force: 2014 update
    Maki, Kevin C., Ridker, Paul M., Brown, W. Virgil, Grundy, Scott M., Sattar, Naveed · 2014 · Journal of Clinical Lipidology